Bioequivalence study of ARQ 197 amorphous and crystalline polymorphs A and B in normal healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2008
At a glance
- Drugs Tivantinib (Primary)
- Indications Colorectal cancer; Gastric cancer; Germ cell and embryonal neoplasms; Liver cancer; Non-small cell lung cancer; Pancreatic cancer; Renal cancer; Soft tissue sarcoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors ArQule
- 21 Jun 2008 Status changed from recruiting to completed.
- 05 May 2008 New trial record.